{"count": 19, "results": [{"_id": "33936830", "pmid": 33936830, "pmcid": "PMC8060102", "title": "Iatrogenic Hypotension Induced by the Improper Treatment of Normal Grief", "journal": "Case Rep Psychiatry", "authors": ["Robinson KE"], "date": "2021-04-13T00:00:00Z", "doi": "10.1155/2021/6661943", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "6661943", "score": 50250.266, "text_hl": "He subsequently developed @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@lightheadedness@@@, and @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@. ", "citations": {"NLM": "Robinson KE. Iatrogenic Hypotension Induced by the Improper Treatment of Normal Grief Case Rep Psychiatry. 2021;2021():6661943. PMID: 33936830", "BibTeX": "@article{33936830, title={Iatrogenic Hypotension Induced by the Improper Treatment of Normal Grief}, author={Robinson KE}, journal={Case Rep Psychiatry}, volume={2021}, pages={6661943}}"}}, {"_id": "2442561", "pmid": 2442561, "title": "The safety and tolerability of lisinopril in clinical trials.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rush JE", "Merrill DD"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198700003-00023", "meta_date_publication": "1987", "meta_volume": "9 Suppl 3", "meta_issue": "", "meta_pages": "S99-107", "score": 50085.863, "text_hl": "@DISEASE_Hypotension @DISEASE_MESH:D007022 @@@Hypotension@@@, @DISEASE_Headache @DISEASE_MESH:D006261 @@@orthostatic effects@@@, or @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ following the initial @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ dose occurred infrequently in @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Rush JE, Merrill DD. The safety and tolerability of lisinopril in clinical trials. J Cardiovasc Pharmacol. 1987;9 Suppl 3():S99-107. PMID: 2442561", "BibTeX": "@article{2442561, title={The safety and tolerability of lisinopril in clinical trials.}, author={Rush JE and Merrill DD}, journal={J Cardiovasc Pharmacol}, volume={9 Suppl 3}, pages={S99-107}}"}}, {"_id": "2550641", "pmid": 2550641, "title": "Clinical experience with lisinopril. Observations on safety and tolerability.", "journal": "J Hum Hypertens", "authors": ["Cameron HA", "Higgins TJ"], "date": "1989-06-01T00:00:00Z", "meta_date_publication": "1989 Jun", "meta_volume": "3 Suppl 1", "meta_issue": "", "meta_pages": "177-86", "score": 50082.004, "text_hl": "In the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ population, the most frequent adverse events reported were @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@, @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ and @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, although not all of these events were thought to be related to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@; 6.1% discontinued @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ due to adverse clinical events, most commonly @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ and @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@. ", "citations": {"NLM": "Cameron HA, Higgins TJ. Clinical experience with lisinopril. Observations on safety and tolerability. J Hum Hypertens. 1989 Jun;3 Suppl 1():177-86. PMID: 2550641", "BibTeX": "@article{2550641, title={Clinical experience with lisinopril. Observations on safety and tolerability.}, author={Cameron HA and Higgins TJ}, journal={J Hum Hypertens}, volume={3 Suppl 1}, pages={177-86}}"}}, {"_id": "7557704", "pmid": 7557704, "title": "[A multicenter study of lisinopril in the treatment of mild to moderate hypertension].", "journal": "Harefuah", "authors": ["Yodfat Y"], "date": "1995-07-01T00:00:00Z", "meta_date_publication": "1995 Jul", "meta_volume": "129", "meta_issue": "1-2", "meta_pages": "26-9, 78", "score": 50074.312, "text_hl": "The efficacy, tolerability and impact on quality of life of the @GENE_AP2B1 @GENE_163 @@@ACE@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ were evaluated in a 12-week open, multicenter post-marketing surveillance study. 233 @SPECIES_9606 @@@patients@@@, 45 years and over with diastolic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@blood pressure@@@ (DBP) 95-105 mm Hg were followed after a washout period of 7 days. 22 withdrew due either to adverse reactions, mainly @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ (4.3%) and @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ (3%), or noncompliance. ", "citations": {"NLM": "Yodfat Y. [A multicenter study of lisinopril in the treatment of mild to moderate hypertension]. Harefuah. 1995 Jul;129(1-2):26-9, 78. PMID: 7557704", "BibTeX": "@article{7557704, title={[A multicenter study of lisinopril in the treatment of mild to moderate hypertension].}, author={Yodfat Y}, journal={Harefuah}, volume={129}, number={1-2}, pages={26-9, 78}}"}}, {"_id": "2839326", "pmid": 2839326, "title": "Lisinopril: a new angiotensin-converting enzyme inhibitor.", "journal": "Drug Intell Clin Pharm", "authors": ["Armayor GM", "Lopez LM"], "date": "1988-05-01T00:00:00Z", "doi": "10.1177/106002808802200501", "meta_date_publication": "1988 May", "meta_volume": "22", "meta_issue": "5", "meta_pages": "365-72", "score": 50071.855, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@: a new angiotensin-converting enzyme inhibitor.", "citations": {"NLM": "Armayor GM, Lopez LM. Lisinopril: a new angiotensin-converting enzyme inhibitor. Drug Intell Clin Pharm. 1988 May;22(5):365-72. PMID: 2839326", "BibTeX": "@article{2839326, title={Lisinopril: a new angiotensin-converting enzyme inhibitor.}, author={Armayor GM and Lopez LM}, journal={Drug Intell Clin Pharm}, volume={22}, number={5}, pages={365-72}}"}}, {"_id": "1665180", "pmid": 1665180, "title": "Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.", "journal": "J Hum Hypertens", "authors": ["Murray NH"], "date": "1991-12-01T00:00:00Z", "meta_date_publication": "1991 Dec", "meta_volume": "5 Suppl 2", "meta_issue": "", "meta_pages": "63-7; discussion 68", "score": 50071.016, "text_hl": "In clinical trials, adverse experiences in @SPECIES_9606 @@@patients@@@ treated with a @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-@CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ combination were @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ (7.5%), @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ (5.2%), @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ (3.9%), @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@ (3.7%), @DISEASE_Headache @DISEASE_MESH:D006261 @@@orthostatic effects@@@ (3.2%), @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ (2.5%), @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@ (2.2%) and @DISEASE_Respiratory_Tract_Infections @DISEASE_MESH:D012141 @@@upper respiratory tract infection@@@ (2.2%). ", "citations": {"NLM": "Murray NH. Review of international safety data for lisinopril-hydrochlorothiazide combination treatment. J Hum Hypertens. 1991 Dec;5 Suppl 2():63-7; discussion 68. PMID: 1665180", "BibTeX": "@article{1665180, title={Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.}, author={Murray NH}, journal={J Hum Hypertens}, volume={5 Suppl 2}, pages={63-7; discussion 68}}"}}, {"_id": "2537560", "pmid": 2537560, "title": "Comparison of lisinopril versus placebo for congestive heart failure.", "journal": "Am J Cardiol", "authors": ["Lewis GR"], "date": "1989-02-21T00:00:00Z", "doi": "10.1016/0002-9149(89)90411-6", "meta_date_publication": "1989 Feb 21", "meta_volume": "63", "meta_issue": "8", "meta_pages": "12D-16D", "score": 50070.83, "text_hl": "Comparison of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ versus placebo for @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@congestive heart failure@@@.", "citations": {"NLM": "Lewis GR. Comparison of lisinopril versus placebo for congestive heart failure. Am J Cardiol. 1989 Feb 21;63(8):12D-16D. PMID: 2537560", "BibTeX": "@article{2537560, title={Comparison of lisinopril versus placebo for congestive heart failure.}, author={Lewis GR}, journal={Am J Cardiol}, volume={63}, number={8}, pages={12D-16D}}"}}, {"_id": "8117550", "pmid": 8117550, "title": "Post-marketing surveillance of lisinopril in general practice in the UK.", "journal": "Br J Clin Pract", "authors": ["Fallowfield JM", "Blenkinsopp J", "Raza A", "Fowkes AG", "Higgins TJ", "Bridgman KM"], "date": "1993-11-01T00:00:00Z", "meta_date_publication": "1993 Nov-Dec", "meta_volume": "47", "meta_issue": "6", "meta_pages": "296-304", "score": 50068.69, "text_hl": "Post-marketing surveillance of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in general practice in the UK.", "citations": {"NLM": "Fallowfield JM, Blenkinsopp J, Raza A, Fowkes AG, Higgins TJ, Bridgman KM. Post-marketing surveillance of lisinopril in general practice in the UK. Br J Clin Pract. 1993 Nov-Dec;47(6):296-304. PMID: 8117550", "BibTeX": "@article{8117550, title={Post-marketing surveillance of lisinopril in general practice in the UK.}, author={Fallowfield JM and Blenkinsopp J and Raza A and Fowkes AG and Higgins TJ and Bridgman KM}, journal={Br J Clin Pract}, volume={47}, number={6}, pages={296-304}}"}}, {"_id": "8390918", "pmid": 8390918, "title": "Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study.", "journal": "Clin Ther", "authors": ["Huckell VF", "Bélanger LG", "Kazimirski M", "Subramanian T", "Cox AJ"], "date": "1993-03-01T00:00:00Z", "meta_date_publication": "1993 Mar-Apr", "meta_volume": "15", "meta_issue": "2", "meta_pages": "407-22", "score": 50065.535, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ was safe and well-tolerated. ", "citations": {"NLM": "Huckell VF, Bélanger LG, Kazimirski M, Subramanian T, Cox AJ. Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study. Clin Ther. 1993 Mar-Apr;15(2):407-22. PMID: 8390918", "BibTeX": "@article{8390918, title={Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study.}, author={Huckell VF and Bélanger LG and Kazimirski M and Subramanian T and Cox AJ}, journal={Clin Ther}, volume={15}, number={2}, pages={407-22}}"}}, {"_id": "10852646", "pmid": 10852646, "title": "Lisinopril: a review of its use in congestive heart failure.", "journal": "Drugs", "authors": ["Simpson K", "Jarvis B"], "date": "2000-05-01T00:00:00Z", "doi": "10.2165/00003495-200059050-00012", "meta_date_publication": "2000 May", "meta_volume": "59", "meta_issue": "5", "meta_pages": "1149-67", "score": 50064.74, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@: a review of its use in @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@congestive heart failure@@@.", "citations": {"NLM": "Simpson K, Jarvis B. Lisinopril: a review of its use in congestive heart failure. Drugs. 2000 May;59(5):1149-67. PMID: 10852646", "BibTeX": "@article{10852646, title={Lisinopril: a review of its use in congestive heart failure.}, author={Simpson K and Jarvis B}, journal={Drugs}, volume={59}, number={5}, pages={1149-67}}"}}]}